Community management of soft tissue infections

From 1 October 2024, invasive group A streptococcal infection (iGAS) has been added to Aotearoa New Zealand’s schedule of notifiable diseases. This places new legal requirements on health practitioners and laboratories for the management and reporting of both suspected and confirmed iGAS cases.

Antibiotic treatment for patients aged 15 years and older with moderate cellulitis funded by ACC. Oral antibiotic therapy is the preferred option.

This BPAC resource assists to predict risk of serious illness in children with fever